It's Expensive, So It Must Be Good

Jan 31, 2009

Over at Genetic Future, Daniel MacArthur is wondering what everyone wants to know: why buy Navigenics' Annual Insight service for $500 when you can have 23andMe's full genome scan for $100 cheaper? Navigenics recently announced an alternative to its $2,500 genetic testing service, the Annual Insight service, which costs $499 and analyzes genetic predisposition for ten common health conditions, including breast cancer, prostate cancer, colon cancer, and heart disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Testing for Reunification Raises Ethics Issues

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

To Make Sure

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

Database of Trees

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

This Week in PLOS

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.

Main menu